Synergy Pharmaceuticals LLC
(Other OTC/NBB : SGYP)

( )
SGYP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
VRXValeant Pharmaceuticals International, Inc. 1.15%27.7514.1%$163.28m
RVMDRevolution Medicines, Inc. -2.04%28.310.0%$120.04m
AMRNAmarin Corp. Plc -0.40%17.621.7%$103.65m
CTLTCatalent, Inc. 1.43%60.452.2%$74.14m
GWPHGW Pharmaceuticals Plc 0.76%127.106.2%$63.90m
JAZZJazz Pharmaceuticals Plc -0.76%140.852.3%$57.99m
AXSMAxsome Therapeutics, Inc. 2.03%90.471.9%$55.25m
UTHRUnited Therapeutics Corp. 0.19%104.1914.3%$48.08m
HZNPHorizon Therapeutics Plc 0.25%35.936.6%$47.36m
ZGNXZogenix, Inc. -0.22%32.189.4%$45.85m
ICPTIntercept Pharmaceuticals, Inc. 0.16%94.8416.9%$45.62m
SAGESAGE Therapeutics, Inc. 0.06%68.088.6%$43.04m
PRGOPerrigo Co. Plc -0.36%57.756.8%$42.41m
ENDPEndo International Plc -0.81%6.158.8%$37.83m
MNKMallinckrodt Plc -8.72%4.5020.9%$35.06m

Company Profile

Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY.